News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
AstraZeneca PLC Plans to Delist Indian Arm, AstraZeneca Pharma India Ltd.
June 29, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SCRIP -- The board of AstraZeneca Pharma India has approved a proposal from its parent company, AstraZeneca Pharma AB, to delist the shares of the Indian arm from local bourses.
Twitter
LinkedIn
Facebook
Email
Print
Asia
AstraZeneca
MORE ON THIS TOPIC
Deals
Lilly deepens relationship with China’s Abbisko for $1.9B biobucks
June 24, 2026
·
2 min read
·
Tristan Manalac
China
BIO 2026: US needs to dodge China’s ‘inescapable dependencies’ to protect biotech
June 24, 2026
·
2 min read
·
Annalee Armstrong
Deals
Nuvectis, Haisco ink up to $1.4B deal for two late-stage programs
June 22, 2026
·
2 min read
·
Gabrielle Masson
Policy
HHS debuts ‘unprecedented’ initiative to ‘restore American leadership’ in clinical trials
June 22, 2026
·
3 min read
·
Heather McKenzie
